were made on whether the ACh-induced phosphorylase a activity in isolated rat uterine muscle segments could he used as a substitute for the contractile response to ACh. This ACh-induced phosphorylase a activity was dependent upon the concentration of ACh and was inhibited by atropine, suggesting that it was linked to muscarinic ACh receptors. Both extracellular calcium and an increase of the intracellular calcium concentration were needed for its activation by ACh. Cat'-antagonists such as Cot+, diltiazem, nitrendipine and verapamil inhibited the ACh-induced activity, suggesting that the activation by ACh required the influx of calcium ions into the uterine muscle through Cat+-antagonist sensitive Cat+ channels. The IC50 values of CoClt, diltiazem, nitrendipine and verapamil on the ACh-induced phosphorylase a activity were 3.4x10-3M, 2.5 X 10-4M, 2.5 X 10-5 M and 1.1 X 10-4 M, respectively. These values were comparable with the IC50 values of these Cat'-antagonists on the contractile response of isolated rat uterine muscle segments to 3X10-4 M ACh. The inhibitory effects of Cot +, nitrendipine and verapamil, but not diltiazem, on ACh-induced phosphorylase a activity were attenuated by higher concentrations of CaClt (0.36 to 2 mM). These findings suggested that the ACh-induced phosphorylase a activity in isolated rat uterine muscle segments could be used as a substitute for the contractile response to ACh.
Calcium/calmodulin-dependent activation of phosphorylase b kinase, which is known to be a key enzyme in the cascade of reactions that regulate glycogen metabolism, has been demonstrated in skeletal (fast) muscle (1, 2), heart (3), liver (4) (5) (6) and uterus (7) , in addition to the adenosine 3",5 cyclic mono phosphate-dependent mechanism (8) . On the other hand, in the uterus, agonists such as acetylcholine (ACh), oxytocin, pro staglandin F2a and serotonin are reported to induce contraction associated with an in crease in the intracellular Cat+ concentration in the uterine muscle (9, 10) . Development of tension in the uterus is thought to depend mainly on extracellular Cat' rather than intracellular Cat+ pools (11) . Therefore, increase in calcium/calmodulin-dependent phosphorylase b kinase activity in uterine muscle may be due to its activation resulting from an increase of intracellular Cat+ in the muscle induced by agonists. Consistent with this idea, in isolated hepatocytes, vasopressin was found to enhance phosphorylase a activity (12). However, the characteristics of enhancement of phosphorylase a activity in uterine smooth muscle by agonists are unknown.
In our work, to determine the primary site of drug action on the contractile response of rat uterine muscle to ACh, we need to search for calcium dependent-reaction system(s) that respond to ACh without involvement of the contractile system(s).
So, in this work, we examined whether the phosphorylase a activity in isolated rat uterine   muscle  segments  was activated  by  ACh and whether  the ACh-induced  phos   phorylase  a activity in the muscle  could be  used  as a substitute  for the  contractile  response to ACh.
Materials and Methods
Preparation of uterine muscle segments: Uterine muscle segments of 17x3-estradiol-3 benzoate treated ovariectomized rats were prepared as described previously (10) . The uterine horns from estradiol-treated ovariec tomized rats were placed in Ringer's solution of the ionic composition described previously (10) at room temperature and bubbled with 5% CO2 in 02. They were then divided longitudinally into several segments (8-12 mg tissue/segment, about 1.5 x 10 mm). Responses to ACh and various agents: The uterine muscle segments were blotted with filter paper, weighed and equilibrated for a minimum of 20 min in Ringer's solution, which was changed every 5 min and bubbled continuously with 5% CO2 in 02 at 30°C. Then each segment was placed in 1 ml of Ringer's solution bubbled with 5% CO2 in 02 at 30°C. The reaction was started by addition of ACh, and the mixture was incubated for 2 min at 30°C, unless otherwise indicated.
When tested, atropine, various Ca antagonists and EGTA were added at 5, 10 and 2 min, respectively, before the addition of ACh. lonomycin was added to the Ringer's solution, and the mixture was incubated for 20 min at 30°C. When Cat+-depleted Ringer's solution [with the ionic composition de scribed previously (10)] was used, the uterine muscle segments were equilibrated in this solution bubbled with 5% CO2 in 02 at 30°C for a minimum of 60 min, and then they were placed in 1 ml of the same solution also bubbled with 5% CO2 1n02 at 30°C.
The reaction was started by addition of ACh, and incubation was continued for 2 min. Test agents were added in volumes amounting to 1.5 to 3.5% of the total reaction system. As a control, the same volume of Ringer [ (294 mCi/ mmol, 105 dpm), 50 mM PIPES (pH 6.4 at 30°C), 100 mM NaF, 1.5% glycogen and 0.75 mM caffeine.
For measurement of total phosphorylase activity, 0.75 M Na2SO4 and 7.5 m M AMP were used instead of caffeine. Phosphorylase activity was assayed at 30'C for 30 min. Then 70 Id of the mixture was removed and promptly spotted on a 1.5 x 1.5 cm square of precreased Whatman 31 ET filter paper. The filter paper was held for several sec after spotting to ensure complete absorption of the reacted mixture, and then it was dropped into a beaker containing 66% ethanol (10 ml/paper) and stirred gently with a stirring bar for 20 min. Then the initial 66% ethanol solution was replaced by the same volume of fresh 66% ethanol and stirred gently for 40 min. After a second washing with ethanol and washing for several minutes with acetone (about 5 ml/ paper), the papers were dried under a heat lamp and transferred to a counting vial with 5 ml of ACS-II (Amersham). Radioactivity was then counted in a liquid scintillation counter (Packard).
ACh-induced phosphorylase a activity was calculated by subtracting the activity of the control without ACh from that with ACh.
Measurement of contractile response: The uterine muscle segments were each placed in a one-ml organ bath containing Ringer's solution and bubbled continuously with 5% CO2 1n02 at 30°C. Results Figure 1 shows the time course change in phosphorylase a activity in uterine muscle segments from estradiol-ovariectomized rats i n the absence and presence of 3 X 10-4 M ACh. The initial phosphorylase a activity on addition of 3x10-4M
ACh was much greater than the basal activity. The basal activity did not change in the 4 min observation period, whereas the ACh-induced phosphorylase a activity increased to a plateau within 30 sec. After 2 min, the activities in the absence and presence of 3x10-4 M ACh were 10 min/mg wet weight, respectively (both n=12). An incubation period of 2 min after addition of 3x10-4M
ACh was used in subsequent experiments, unless otherwise indicated.
The time course of change in ACh-induced phosphorylase a activity was similar to that of the contractile response of isolated rat uterine muscle segments to 3x10-4 M ACh, as shown in Fig. 1 and previous work (16) .
The ACh-induced phosphorylase a activity was dependent upon the concentration of ACh (Fig. 2) . The concentration of ACh for half-maximal activity was 3.7±0.6x10-6 M (n=10). This ED50 value of ACh was com parable to the ED50 of ACh (10) in the con tractile response of isolated rat uterine muscle segments. The phosphorylase a activities with various concentrations of ACh were in hibited almost completely by 1 /iM atropine, a concentration that completely inhibits the contractile response of isolated uterine muscle segments to 3X10-4 M ACh (S. Ichida et al., unpublished data), suggesting that the ACh induced phosphorylase a activity is linked to muscarinic ACh receptors.
Scarcely any ACh-induced phosphorylase a activity was observed under conditions in which the extracellular concentration of calcium ion was low, such as when (a) EGTA (1 mM) was added to the muscle bath containing Ringer's solution 2 min before addition of ACh or (b) Ca-depleted Ringer's solution was used instead of Ringer's solution (Fig. 3) . and presence (-0-) of 3x10-4 M ACh as described under Materials and Methods.
ACh-induced phosphorylase a activity was calculated by subtracting the phosphorylase a activity without ACh (control) from the activity with ACh. The contractile responses were measured by the addition of 3x10-4 M ACh (---A---) as described under Materials and Methods.
Points are means for four to twelve separate animals. Bars indicate standard errors. and presence (-0-) of atropine as described under Materials and Methods. Atropine (1 aM) was added to the muscle bath 5 min before addition of ACh. Points are means for five to ten separate animals.
Bars indicate standard errors. lonomycin activated phosphorylase a activity dose-dependently, although the extent of the enzyme activation induced by 3x10-6 M ionomycin was about half that induced by 10-4 M ACh. These findings suggested that the activation of phosphory lase a induced by ACh was dependent upon extracellular calcium and also that the increase in intracellular calcium concentration required the activation of this enzyme. As shown in Fig. 4-A , B, C and D, respec tively, phosphorylase a activity induced by 3x10-4 M ACh was inhibited by Cot+, diltiazem, nitrendipine and verapamil. These findings and the data in Fig. 3 suggest that the activation of phosphorylase a induced by ACh in uterine muscle cells requires an intracellular flow of calcium ions through Cat'-antagonist sensitive Ca2+ channels. The IC50 values of CoCl2, diltiazem, ni trendipine and verapamil on ACh-induced phosphorylase a activity were 3.4±0.7x 10-3 M (n=6), 2.5±0.6x10-4 M (n=4), 2.5±0.8x 10-5 M (n=4) and 1.1 ±0.4x10-4 M (n=8), respectively. These values were comparable with the IC50 values of these Ca-antagonists on the contractile responses of rat uterine muscle segments to 3 x 10-4 M ACh as shown in Table 1 , but the IC50 values of diltiazem for these two responses differed by about one order of magnitude.
Increasing the concentration of CaC12 from 0.36 mM to 2 mM in Ringer's solution significantly attenuated the inhibitory effects of 6x10-3 M CoCl2, 10-4 M nitrendipine and 10-3 M verapamil, but not that of 3 x 10-3 M diltiazem (Fig. 5) . Discussion The main findings in the present study were as follows: 1) Phosphorylase a activity of isolated rat uterine muscle segments was rapidly activated by ACh.
2) The ACh induced phosphorylase a activity was de pendent upon the concentrations of ACh and was inhibited by atropine. 3) Scarcely any ACh-induced phosphorylase a activity was observed under conditions in which the concentration of calcium ion in the reaction medium was lowered by either addition of EGTA or replacement of Ringer by Ca depleted Ringer. 4) The ACh-induced phos phorylase a activity was inhibited by Cot+, diltiazem, nitrendipine or verapamil. The inhibitory effects of Cot', nitrendipine and verapamil, but not that of diltiazem, were at tenuated by higher concentrations of CaCl2 (0.36 mM to 2 mM). Points are means for four to eight separate animals. Bars indicate standard errors.
In this work, the total phosphorylase activity of rat uterine muscle segments was 40.1±2.5 (n=12) nmol [14C]glucose incor porated/30 min/mg wet weight. This value was comparable with the values reported by most others (14, 15), but not that reported by Gilboe et al. (13) .
Results with Ca-depleted Ringer's solu tion, EGTA and ionomycin (Fig. 3) showed that activation of phosphorylase a by ACh in rat uterine muscle segments required both extracellular calcium ions and increase in the intracellular concentration of calcium ions. These findings suggest that the ACh induced flow of extracellular calcium ions into the cells through Ca2+ channels in the uterine muscle cells causes both a con tractile response and activation of phos phorylase a.
Various characteristics of ACh-induced phosphorylase a activities such as the time course of change in activity (Fig. 1) , the ED50 value of ACh (Fig. 2) , the IC50 values of various Ca2+ antagonists (Fig. 4-A Table 1 of this paper and data in ref. (10)], although the two responses differed in their IC50 values for diltiazem and the attenuating effects of higher Ca2+ con centrations in the inhibition by diltiazem. Therefore, these findings suggested that the ACh-induced phosphorylase a activity in uterine muscle can be used as a substitute for the contractile response to ACh. (Table 1 of this paper and data in ref. 10). The reason for these differences is unknown, but it might be because diltiazem affects the level of cAMP and/or the availability of calmodulin, since phosphorylase a~ activity was reported to be changed indirectly by fluctuation (s) in the level of cAMP and/or the availability of calmodulin (1, 3-5, 7, 8) .
The IC50 values of diltiazem, nitrendipine and verapamil on the contractile response to ACh observed in this work (Table 1 ) differed by about one to two orders of magnitude from those for inhibitions of the contractile responses of isolated uterine muscles from rats and mice reported by others (10, 17 20) . The reason for this difference is un known. However, the differences in the IC50 values for Cat'-antagonists in our previous (10) and present studies may be due to the following differences of experimental con ditions: 1) In our previous work (10), the IC50 values of diltiazem and verapamil were obtained from rat uterine muscle segments that were incubated in Ca-depleted Ringer's solution (the same composition as Ringer, but without Ca2+ and with 0.1 mM EGTA) for a minimum of 60 min, but in this work, the inhibitory effect of Ca2+-antagonists was examined in Ringer's solution (containing Ca2+ but without EGTA), 2) In this work, for comparison of the IC50 values of Ca2+_ antagonists on ACh-induced phosphorylase a activity, the experimental conditions for examining inhibitory effects of Ca2+-an tagonists on contractile response to ACh were the same as those for measuring ACh induced phosphorylase a activity. That is, uterine muscle segments were tested once with one concentration of a Ca2+-antagonist. On the other hand, in the previous work (10) , uterine muscle segments were tested with several concentrations (from a low to high concentration) of a Ca2+-antagonist, but we had to confirm that there was no change in the contractile responses to 3x10-4 M ACh as a control between the additions of one dose and the next of a Ca2+-antagonist.
As suggested in this work, the characteris tics of the activation of phosphorylase a by ACh in isolated rat uterine muscle segments were comparable with those of the con tractile response of the muscle segments to ACh. The results of our work suggest that the ACh-induced phosphorylase a activity in isolated rat uterine muscle segments can be used as a substitute for the contractile re sponse to ACh. Therefore, studies using ACh induced phosphorylase a activity of rat uterine segments should be very useful for clarifying whether the primary site of drug action on the contractile response of the muscle segments to ACh exists in a calcium dependent-reaction system of the muscle segments, because ACh-induced phos phorylase a activity is considered to be a calcium dependent-reaction system to ACh that does not involve the contractile system(s) in the muscle segments.
